Prenatal Azithromycin Exposure and Risk of Neurodevelopmental Disorders in Children - Scorecard - MDSpire

Prenatal Azithromycin Exposure and Risk of Neurodevelopmental Disorders in Children

  • By

  • Marianne N. Otoo

  • Kimford J. Meador

  • Todd Brothers

  • Thomas Lavoie

  • Nicole J. Asal

  • Brian J. Quilliam

  • Don Keon Yon

  • Carmen Monthe-Dreze

  • Kristina E. Ward

  • Jing Wu

  • Adam K. Lewkowitz

  • Xuerong Wen

  • May 12, 2026

  • 0 min

Share

Clinical Scorecard: The Impact of Prenatal Exposure to Azithromycin on the Development of Neurodevelopmental Disorders in Offspring

At a Glance

CategoryDetail
Condition
Key MechanismsExpand to include potential risks beyond mitochondrial dysfunction and oxidative damage.
Target Population
Care Setting

Key Highlights

  • additional_data

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • S
      • p
      • e
      • c
      • i
      • f
      • y
      • f
      • o
      • l
      • l
      • o
      • w
      • -
      • u
      • p
      • t
      • i
      • m
      • e
      • l
      • i
      • n
      • e
      • s
      • o
      • r
      • a
      • s
      • s
      • e
      • s
      • s
      • m
      • e
      • n
      • t
      • s
      • f
      • o
      • r
      • N
      • D
      • D
      • s
      • .

      Risks

        Patient & Prescribing Data

        Clinical Best Practices

        • evidence_based

        References

        Original Source(s)

        Related Content